Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise
beta
Latest Financials
Filings:
By Category
By Date
Search Filings
Institutional Holders
beta
Earnings Transcripts
beta
Global Search
Company Exhibits:
Indentures
Material Contracts & Credit Agreements
Plans of Reorganization
Articles and Bylaws
Underwriting Agreements
SEC Edgar
CYTEC INDUSTRIES INC/DE/
SIC 2890 · Miscellaneous Chemical Products
Notes
Support
about
terms
Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise.com
Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise.com
beta
Latest Financials
Filings:
Category
Date
Search Filings
Institutional Holders
beta
Earnings Transcripts
beta
Global Search
SEC Edgar
CYTEC INDUSTRIES INC/DE/
SIC 2890 · Miscellaneous Chemical Products
Notes
Support
about
terms
Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise.com
beta
Latest Financials
Filings:
Category
Date
Search Filings
Institutional Holders
beta
Earnings Transcripts
beta
Global Search
SEC Edgar
CYTEC INDUSTRIES INC/DE/
SIC 2890 · Miscellaneous Chemical Products
Notes
Support
about
terms
CYTEC INDUSTRIES INC/DE/
CIK:
0000912513
|
SEC Filings
Income Statement
Cash Flow
Balance Sheet
v3.3.0.814
CONSOLIDATED STATEMENTS OF INCOME - USD ($)
$ in Millions
3 Months Ended
9 Months Ended
Sep. 30, 2015
Sep. 30, 2014
Sep. 30, 2015
Sep. 30, 2014
Income Statement [Abstract]
Net sales
$ 497.3
$ 506.8
$ 1,520.5
$ 1,523.0
Manufacturing cost of sales
326.8
342.0
1,040.4
1,018.2
Selling and technical services
35.4
35.3
106.9
109.6
Research and process development
12.8
12.0
37.3
37.2
Administrative and general
34.7
31.0
95.2
93.3
Amortization of acquisition intangibles
3.4
3.6
10.3
10.9
Earnings from operations
84.2
82.9
230.4
253.8
Other expense, net
1.5
1.6
3.0
2.2
Interest expense, net
4.0
3.1
11.6
9.3
Earnings from continuing operations before income taxes
78.7
78.2
215.8
242.3
Income tax provision
19.2
24.4
57.6
70.2
Earnings from continuing operations
59.5
53.8
158.2
172.1
Net (loss) gain on sale of discontinued operations, net of tax
0.0
(0.2)
(1.5)
11.0
(Loss) earnings from discontinued operations, net of tax
0.0
(0.2)
(1.5)
11.0
Net earnings
59.5
53.6
156.7
183.1
Comprehensive income
$ 30.7
$ 2.1
$ 89.5
$ 134.1
Basic earnings per common share
Continuing operations
$ 0.83
$ 0.74
$ 2.20
$ 2.38
Discontinued operations
0.00
0.00
(0.02)
0.15
Basic earnings (loss) per common share:
0.83
0.74
2.18
2.53
Diluted earnings per common share
Continuing operations
0.81
0.73
2.16
2.34
Discontinued operations
0.00
0.00
(0.02)
0.15
Diluted earnings (loss) per common share:
0.81
0.73
2.14
2.49
Dividends per common share
$ 0.125
$ 0.125
$ 0.375
$ 0.250
v3.3.0.814
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Millions
9 Months Ended
Sep. 30, 2015
Sep. 30, 2014
Cash flows provided by (used in) operating activities
Net earnings
$ 156.7
$ 183.1
(Loss) earnings from discontinued operations, net of tax
(1.5)
11.0
Net earnings from continuing operations
158.2
172.1
Adjustments to reconcile net income to net cash provided by operating activities of continuing operations:
Depreciation
52.1
46.5
Amortization
13.4
13.5
Share-based compensation
10.0
9.8
Deferred income taxes
5.4
18.8
Pension and postretirement benefit (income) expense
(2.3)
0.7
Contributions to pension and postretirement plans
(11.6)
(10.6)
Non-cash loss on disposal of assets
0.9
1.9
Unrealized (gain) loss on foreign currency forward contracts
(5.8)
7.9
Changes in operating assets and liabilities:
Trade accounts receivable
(38.0)
(50.1)
Other receivables
4.3
(5.6)
Inventories
(11.8)
(48.7)
Other assets
(5.0)
1.1
Accounts payable
13.3
22.4
Accrued expenses
(19.0)
(1.6)
Income taxes payable
(2.5)
4.2
Other liabilities
(1.6)
(10.6)
Net cash provided by operating activities of continuing operations
160.0
171.7
Net cash (used in) provided by operating activities of discontinued operations
(3.2)
0.3
Net cash provided by operating activities
156.8
172.0
Cash flows used in investing activities:
Additions to plants, equipment and facilities
(96.9)
(170.3)
Other investing activities, net
0.0
(0.1)
Net cash used in investing activities
(96.9)
(170.4)
Cash flows provided by (used in) financing activities:
Proceeds from long-term debt
0.5
1.3
Payments on long-term debt
(0.9)
(0.4)
Proceeds from (Repayments of) Short-term Debt
0.0
2.9
Dividends, Cash
(26.8)
(17.9)
Proceeds from the exercise of stock options
9.9
14.3
Excess tax benefits from share-based payment arrangements
3.8
6.7
Net cash (used in) provided by financing activities
(13.5)
6.9
Effect of currency rate changes on cash and cash equivalents
(9.4)
(7.7)
Increase in cash and cash equivalents
37.0
0.8
Cash and cash equivalents, beginning of period
133.9
151.8
Cash and cash equivalents, end of period
$ 170.9
$ 152.6
v3.3.0.814
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Millions
Sep. 30, 2015
Dec. 31, 2014
Current assets
Cash and cash equivalents
$ 170.9
$ 133.9
Trade accounts receivable, less allowance for doubtful accounts of $3.5 and $3.8 at September 30, 2015 and December 31, 2014, respectively
286.2
265.1
Other accounts receivable
72.9
74.6
Inventories
309.4
307.6
Deferred income taxes
35.1
27.4
Other current assets
21.9
26.2
Total current assets
896.4
834.8
Plants, equipment and facilities, at cost
1,699.7
1,680.8
Less: accumulated depreciation
(589.0)
(559.4)
Net plant investment
1,110.7
1,121.4
Acquisition intangibles, net of accumulated amortization of $80.1 and $70.8 at September 30, 2015 and December 31, 2014, respectively
128.7
141.6
Goodwill
502.0
508.8
Deferred income taxes
32.8
41.2
Other assets
137.5
119.4
Total assets
2,808.1
2,767.2
Current liabilities
Accounts payable
179.1
172.4
Current maturities of long-term debt
1.5
1.2
Accrued expenses
160.3
184.6
Income taxes payable
9.2
8.4
Deferred income taxes
0.4
0.3
Total current liabilities
350.5
366.9
Liabilities
Long-term debt
740.1
741.7
Pension and other postretirement benefit liabilities
229.1
245.9
Other noncurrent liabilities
156.3
170.3
Deferred income taxes
34.5
31.4
Stockholders’ equity
Preferred stock, 20,000,000 shares authorized; none issued and outstanding
0.0
0.0
Common stock, $.01 par value per share, 150,000,000 shares authorized; issued 99,822,154 at September 30, 2015 and 99,772,436 at December 31, 2014
1.0
1.0
Additional paid-in capital
481.7
474.2
Retained earnings
1,829.3
1,699.6
Accumulated other comprehensive (loss) income
(54.1)
13.1
Treasury stock, at cost, 28,275,035 shares at September 30, 2015 and 28,732,931 shares at December 31, 2014
(960.3)
(976.9)
Total stockholders’ equity
1,297.6
1,211.0
Total liabilities and stockholders’ equity
$ 2,808.1
$ 2,767.2